SW-620 cells treated with topoisomerase I inhibitor SN-38: gene expression profiling
- PMID: 16375766
- PMCID: PMC1368997
- DOI: 10.1186/1479-5876-3-44
SW-620 cells treated with topoisomerase I inhibitor SN-38: gene expression profiling
Abstract
Background: The goal of this study was to evaluate changes in gene expression in SW-620 cells in response to SN-38 in order to further elucidate the mechanisms by which SN-38 causes apoptosis and cell cycle arrest.
Methods: We used a quantitative gene expression microarray assay to identify the genes regulated by SN-38 treatment in colon cancer cells and confirmed our results with RT-PCR. By gene expression profiling, we first screened a proprietary list of about 22,000 genes.
Results: Treatment with SN-38 cells resulted in two-fold or greater alteration in the level of expression of 192 genes compared to control treatment. Most of the affected genes were not known to be responsive to SN-38 prior to this study. SN-38 treatment of these cells was found to affect the expression of various genes involved in DNA replication, transcription, signal transduction, growth factors, cell cycle regulation, and apoptosis, as well as other genes with unknown function. Changes in expression of 14 genes were confirmed by quantitative real-time polymerase chain reaction (RT-PCR).
Conclusion: This study leads to an increased understanding of the biochemical pathways involved in SN-38-induced apoptosis and possibly to the identification of new therapeutic targets.
Figures

Similar articles
-
Gene expression profiling of E2F-1-induced apoptosis.Gene. 2005 Jan 3;344:67-77. doi: 10.1016/j.gene.2004.09.030. Epub 2004 Nov 23. Gene. 2005. PMID: 15656974
-
Gene expression profile of colon cancer cell lines treated with SN-38.Chemotherapy. 2010;56(1):17-25. doi: 10.1159/000287353. Epub 2010 Feb 24. Chemotherapy. 2010. PMID: 20185912
-
Taurine-responsive genes related to signal transduction as identified by cDNA microarray analyses of HepG2 cells.J Med Food. 2006 Spring;9(1):33-41. doi: 10.1089/jmf.2006.9.33. J Med Food. 2006. PMID: 16579726
-
Expression profiling of sodium butyrate (NaB)-treated cells: identification of regulation of genes related to cytokine signaling and cancer metastasis by NaB.Oncogene. 2004 Aug 19;23(37):6304-15. doi: 10.1038/sj.onc.1207852. Oncogene. 2004. PMID: 15318170
-
[Influence of crocin on gene expression profile of human bladder cancer cell lines T24].Zhongguo Zhong Yao Za Zhi. 2008 Jul;33(13):1612-7. Zhongguo Zhong Yao Za Zhi. 2008. PMID: 18837328 Chinese.
Cited by
-
In vivo topoisomerase I inhibition attenuates the expression of hypoxia-inducible factor 1α target genes and decreases tumor angiogenesis.Mol Med. 2012 Feb 10;18(1):83-94. doi: 10.2119/molmed.2011.00120. Mol Med. 2012. PMID: 22033674 Free PMC article.
-
In Vitro Global Gene Expression Analyses Support the Ethnopharmacological Use of Achyranthes aspera.Evid Based Complement Alternat Med. 2013;2013:471739. doi: 10.1155/2013/471739. Epub 2013 Dec 15. Evid Based Complement Alternat Med. 2013. PMID: 24454496 Free PMC article.
-
SN38-PEG-PLGA-verapamil nanoparticles inhibit proliferation and downregulate drug transporter ABCG2 gene expression in colorectal cancer cells.Prog Biomater. 2017 Dec;6(4):137-145. doi: 10.1007/s40204-017-0073-y. Epub 2017 Sep 25. Prog Biomater. 2017. PMID: 28948511 Free PMC article.
-
UNR/CSDE1 Expression Is Critical to Maintain Invasive Phenotype of Colorectal Cancer through Regulation of c-MYC and Epithelial-to-Mesenchymal Transition.J Clin Med. 2019 Apr 25;8(4):560. doi: 10.3390/jcm8040560. J Clin Med. 2019. PMID: 31027221 Free PMC article.
-
Topoisomerase I inhibitor SN-38 effectively attenuates growth of human non-small cell lung cancer cell lines in vitro and in vivo.J Environ Pathol Toxicol Oncol. 2011;30(1):1-10. doi: 10.1615/jenvironpatholtoxicoloncol.v30.i1.10. J Environ Pathol Toxicol Oncol. 2011. PMID: 21609311 Free PMC article.
References
-
- Chen Z, Furukawa T, Sumizawa T, Ono K, Ueda K, Seto K, Akiyama S. ATP-dependent efflux of CPT-11 and SN-38 by the multidrug resistance protein (MRP) and its inhibition by PAK-104P. Mol Pharmacol. 1999;55:921–928. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources